»ó´Ü¿©¹é
±â»ç (Àüü 947°Ç)
[Deep in Guideline] ´ç´¢º´ ¸ÂÃãÄ¡·á ÇâÇØ ÇÑ ¹ß ´õ ÀüÁø Áß ÀÓ¼¼Çü ±âÀÚ 2021-02-02 10:22
[Interview] Àν¶¸° ÀúÇ×¼ºÀÇ ÇØ´ä, Ãʱâ TZD Àü·«¿¡¼­ ã´Â´Ù ÀÓ¼¼Çü ±âÀÚ 2021-02-01 17:45
[Sub Story] CKD ȯÀÚ ½ÉÇ÷°ü À§Çè °ü¸®¿¡µµ SGLT-2I¡¤GLP-1RA ±Ç°í ÀÓ¼¼Çü ±âÀÚ 2021-02-01 15:40
[Sub Story] ¿¥ÆÄ±Û¸®Ç÷ÎÁø ¡®½ÉºÎÀü¡¤½ÅÀåÁúȯ¡¯ ¾à¹°·Î ÀÚ¸®¸Å±è ÀÓ¼¼Çü ±âÀÚ 2021-02-01 15:39
[Sub Story] Áö¼ÓÀûÀÎ 1³â 1ȸ Æò°¡ ÅëÇÑ ½Å°æº´Áõ ¡®¿¹¹æ¡¯¿¡ ¹«°Ô ÀÓ¼¼Çü ±âÀÚ 2021-02-01 15:27
¶óÀÎ
[Interview] ¡°¸ÂÃãÄ¡·á Ãø¸é¿¡¼­ CGM ¿ªÇÒ Ä¿Áö´Â Áß¡± ÀÓ¼¼Çü ±âÀÚ 2021-02-01 15:09
[Cover Story] ¾Ï ¿¹¹æ ¿°µÎ¿¡ µÐ ¼ÒÈ­±âÁúȯ °ü¸®Àü·« ÀÓ¼¼Çü ±âÀÚ 2021-01-22 13:45
[Sub Story] Ç︮ÄÚ¹ÚÅÍ Á¦±ÕÄ¡·á Ç×»ýÁ¦¿¡¼­ P-CAB±îÁö ÀÓ¼¼Çü ±âÀÚ 2021-01-22 13:15
[Sub Story] ¼ÒÈ­ºÒ·®Áõ Áø´Ü ¶§ºÎÅÍ À§¾Ï ¿©ºÎÈ®ÀÎ °­Á¶ ÀÓ¼¼Çü ±âÀÚ 2021-01-22 12:00
[Interview] ¡°¼ÒÈ­ºÒ·® ¾ÆÇü Áß½É Ä¡·áÀü·« Á¦½Ã¡± ÀÓ¼¼Çü ±âÀÚ 2021-01-22 11:56
¶óÀÎ
[Sub Story] C.difficile °íÀ§Ç豺¿¡ ÇÁ·Î¹ÙÀÌ¿Àƽ½º ±Ç°í ÀÓ¼¼Çü ±âÀÚ 2021-01-22 11:51
[Drug Review] ¡®±Ù°Å ±â¹Ý¡¯ ÇÁ·Î¹ÙÀÌ¿Àƽ½º·Î ³ª°¡´Â Áß ÀÓ¼¼Çü ±âÀÚ 2021-01-22 11:45
[Sub Story] ¾Æ½ºÇǸ° + Ç×Ç÷¼ÒÆÇÁ¦ ¼ÒÈ­¼º±Ë¾ç À§Çè¡è ÀÓ¼¼Çü ±âÀÚ 2021-01-22 11:38
[Sub Story] DAA-µ¿¹ÝÁúȯ ¾àÁ¦ °£ »óÈ£ÀÛ¿ë °­Á¶ ÀÓ¼¼Çü ±âÀÚ 2021-01-22 11:33
[Sub Story] À¯ÀüÀÚÇü¡¤Ä¡·áº´·Â¡¤°£°æº¯Áõ È®ÀÎ °­Á¶ ÀÓ¼¼Çü ±âÀÚ 2021-01-22 11:23
¶óÀÎ
[Sub Story] HBV ¾àÁ¦³»¼º¡¤ÀçȰ¼ºÈ­ °ü¸®¿¡ ¹«°Ô ÀÓ¼¼Çü ±âÀÚ 2021-01-22 11:18
[Conference Report] °£¿° °ü¸®, °£¾Ï À§Çè °¨¼Ò·Î Á÷°á ÀÓ¼¼Çü ±âÀÚ 2021-01-22 11:04
[Conference Report] CÇü°£¿° Ä¡·áÅëÇÑ °£¾Ï À§Çè °¨¼Ò È®ÀÎ ÀÓ¼¼Çü ±âÀÚ 2021-01-22 10:57
[Interview] ¡°°íÀ§Çè CAD¿¡¼­ ACEI ÀÔÁö È®ÀÎÇß´Ù¡± ÀÓ¼¼Çü ±âÀÚ 2021-01-22 10:53
[Drug Review] ´Ã¾î³ª´Â NSAIDs ¼ÒÈ­¼º±Ë¾ç ¿¹¹æ ´ë¾È ÀÓ¼¼Çü ±âÀÚ 2021-01-22 10:45
Back to Top